KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma

AIMS: Pulmonary sarcomatoid carcinoma (PSC) is a poorly differentiated non-small-cell lung carcinoma (NSCLC) with aggressive behaviour. This study aimed to evaluate the prognostic clinicopathological and genetic characteristics of PSCs. METHODS AND RESULTS: Fifty-three cases of surgically treated PS...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Histopathology
Main Authors: Mehrad, Mitra, Roy, Somak, LaFramboise, William A, Petrosko, Patti, Miller, Caitlyn, Incharoen, Pimpin, Dacic, Sanja
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7393997/
https://ncbi.nlm.nih.gov/pubmed/29489023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/his.13505
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki